Stay updated with breaking news from Amarin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cutter & CO Brokerage Inc. trimmed its holdings in Amarin Co. plc (NASDAQ:AMRN – Free Report) by 17.2% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 441,601 shares of the biopharmaceutical company’s stock after selling 91,850 shares during the quarter. Cutter & CO Brokerage Inc. owned […]
Amarin Co. plc (NASDAQ:AMRN – Get Free Report) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 18,190,000 shares, an increase of 7.1% from the February 29th total of 16,990,000 shares. Based on an average trading volume of 2,310,000 shares, the days-to-cover ratio […]
Amarin Corporation plc (AMRN) announced it received a Decision to Grant from the European Patent Office for a new patent covering VAZKEPA that will extend VAZKEPA exclusivity eight additional years into 2039.
There was unambigously good news about the company's single commercialized medication.
In reality, we see that the dream of a balance between economic growth and prosperity with natural conservation only exists when the unseemly aspects of development can be shunted to